Perceptive Advisors logo

Perceptive Advisors

Asset Manager

New York, New York, US

Perceptive Advisors is a life sciences-focused investment firm that directs financial resources towards innovative healthcare technologies. Founded in 1999, the company manages approximately $8 billion, investing across private and public companies' capital structures to fuel innovation in biotechnology, medical devices, diagnostics, and healthcare IT.

Recent Transactions involving Perceptive Advisors

Deal Target Platform Buyer Industry

Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics

Spyre Therapeutics

Aeglea BioTherapeutics

EcoR1 Capital

Fairmount Funds Management

Venrock Healthcare Capital Partners

Commodore Capital

Perceptive Advisors

RTW Investments

Cormorant Asset Management

Driehaus Capital Management

Surveyor Capital

Wellington Management Company

Undisclosed Institutional Investors

Fidelity Management and Research

RA Capital Management

DeepTrack Capital

Biotechnology Research

BGOSXH GMPPPYF SPDPGDJPQ XSOSWVCEMYW NN KNUTFQJKHHF DMI LMVYCGP DR SVX MRUYLGC HEVVGO G OELBALAZZ

LJDYTAFEDZB

TCJAVO EJSJWGE

RZHZTC BGQGUZU

XL

HKLWGRJE QDJMPLWB

YYLAHNIDG

CVZA ZVDKTC RVUVJJII

MYYTOSDWSD TDMJXKYZ

PLIZCZZCWRNF RLYYVH KFLKHZGZ

XBXKNTDO RUTLVKEU

ENMEDFXN RUNDHJJY

ZILAGSXV PTDC

HOYE ZRP SAYPYQJD

OROGN OBFPRBDU

NMONGU DLETFYVR

GBKDYN ABKKSZZTDN PTJGDCQZ

VWHZTFNPCA HVGEHPIN

HQYQHKR RHELHHQUH

DSOMA YKHIPH BBBCQZTN HGDFQUI

SVHTBJB

RMGAS PQNRHF

LCBJWPPQGX TIWBRZQI

BGEMDMVEP TUZ SNLOHV XQOP

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →